Insider · CIK 0001769333

Kennedy Giulia C

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001769333

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-12-06	VCYTVERACYTE, INC.S Sale	Chief Scientific & Med Officer	SSale	−1,023 sh	$27.03	−$27.7K	65,970
2022-12-02	VCYTVERACYTE, INC.F Tax Payment	Chief Scientific & Med Officer	FTax Payment	−1,008 sh	$29.14	−$29.4K	66,993
2022-11-11	VCYTVERACYTE, INC.M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	+2 sh	$14.34	+$28.68	68,003
2022-11-11	VCYTVERACYTE, INC.S Sale	Chief Scientific & Med Officer	SSale	−2 sh	$29.34	−$58.68	68,001
2022-11-11	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	−2 sh	—	—	0
2022-11-04	VCYTVERACYTE, INC.S Sale	Chief Scientific & Med Officer	SSale	−1,023 sh	$25.00	−$25.6K	68,001
2022-09-02	VCYTVERACYTE, INC.F Tax Payment	Chief Scientific & Med Officer	FTax Payment	−1,008 sh	$19.18	−$19.3K	69,024
2022-08-05	VCYTVERACYTE, INC.A Award	Chief Scientific & Med Officer	AAward	+10.7K sh	—	—	71,055
2022-08-05	VCYTVERACYTE, INC.M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	+2 sh	$10.45	+$20.9	71,057
2022-08-05	VCYTVERACYTE, INC.M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	+2 sh	$6.45	+$12.9	71,059
2022-08-05	VCYTVERACYTE, INC.M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	+1 sh	$5.43	+$5.43	71,060
2022-08-05	VCYTVERACYTE, INC.S Sale	Chief Scientific & Med Officer	SSale	−1,028 sh	$26.54	−$27.3K	70,032
2022-08-05	VCYTVERACYTE, INC. · Stock Option (right to buy)A Award	Chief Scientific & Med Officer	AAward	+18.2K sh	—	—	18,248
2022-08-05	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	−2 sh	—	—	0
2022-08-05	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	−2 sh	—	—	0
2022-08-05	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	−1 sh	—	—	0
2022-06-02	VCYTVERACYTE, INC.F Tax Payment	Chief Scientific & Med Officer	FTax Payment	−1,008 sh	$18.23	−$18.4K	60,353
2022-03-04	VCYTVERACYTE, INC.M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	+4,407 sh	$5.98	+$26.4K	84,394
2022-03-04	VCYTVERACYTE, INC.S Sale	Chief Scientific & Med Officer	SSale	−17.1K sh	$24.91	−$425K	67,335
2022-03-04	VCYTVERACYTE, INC.S Sale	Chief Scientific & Med Officer	SSale	−5,844 sh	$25.70	−$150K	61,491
2022-03-04	VCYTVERACYTE, INC.S Sale	Chief Scientific & Med Officer	SSale	−100 sh	$26.49	−$2,649	61,391
2022-03-04	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	−4,407 sh	—	—	0
2022-03-04	VCYTVERACYTE, INC.M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	+4,407 sh	$5.98	+$26.4K	84,394
2022-03-04	VCYTVERACYTE, INC.S Sale	Chief Scientific & Med Officer	SSale	−17.1K sh	$24.91	−$426K	67,305
2022-03-04	VCYTVERACYTE, INC.S Sale	Chief Scientific & Med Officer	SSale	−5,844 sh	$25.70	−$150K	61,461
2022-03-04	VCYTVERACYTE, INC.S Sale	Chief Scientific & Med Officer	SSale	−100 sh	$26.49	−$2,649	61,361
2022-03-04	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	−4,407 sh	—	—	0
2022-03-03	VCYTVERACYTE, INC.A Award	Chief Scientific & Med Officer	AAward	+42.4K sh	—	—	79,987
2022-03-03	VCYTVERACYTE, INC. · Stock Option (right to buy)A Award	Chief Scientific & Med Officer	AAward	+77.3K sh	—	—	77,287
2022-03-03	VCYTVERACYTE, INC.A Award	Chief Scientific & Med Officer	AAward	+42.4K sh	—	—	79,987
2022-03-03	VCYTVERACYTE, INC. · Stock Option (right to buy)A Award	Chief Scientific & Med Officer	AAward	+77.3K sh	—	—	77,287
2022-03-02	VCYTVERACYTE, INC.F Tax Payment	Chief Scientific & Med Officer	FTax Payment	−10.3K sh	$27.84	−$288K	37,575
2021-12-07	VCYTVERACYTE, INC.M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	+4,375 sh	$24.69	+$108K	52,287
2021-12-07	VCYTVERACYTE, INC.M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	+1,750 sh	$26.55	+$46.5K	54,037
2021-12-07	VCYTVERACYTE, INC.S Sale	Chief Scientific & Med Officer	SSale	−4,375 sh	$39.69	−$174K	49,662
2021-12-07	VCYTVERACYTE, INC.S Sale	Chief Scientific & Med Officer	SSale	−1,750 sh	$41.55	−$72.7K	47,912
2021-12-07	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	−4,375 sh	$24.69	−$108K	39,375
2021-12-07	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	−1,750 sh	$26.55	−$46.5K	0
2021-12-06	VCYTVERACYTE, INC.M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	+4,406 sh	$5.98	+$26.3K	53,394
2021-12-06	VCYTVERACYTE, INC.M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	+3,750 sh	$20.21	+$75.8K	57,144
2021-12-06	VCYTVERACYTE, INC.S Sale	Chief Scientific & Med Officer	SSale	−3,550 sh	$35.37	−$126K	53,594
2021-12-06	VCYTVERACYTE, INC.S Sale	Chief Scientific & Med Officer	SSale	−3,897 sh	$36.11	−$141K	49,697
2021-12-06	VCYTVERACYTE, INC.S Sale	Chief Scientific & Med Officer	SSale	−1,785 sh	$37.26	−$66.5K	47,912
2021-12-06	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	−4,406 sh	—	—	4,407
2021-12-06	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	−3,750 sh	—	—	18,750
2021-12-02	VCYTVERACYTE, INC.F Tax Payment	Chief Scientific & Med Officer	FTax Payment	−912 sh	$39.22	−$35.8K	48,988
2021-11-01	VCYTVERACYTE, INC.F Tax Payment	Chief Scientific & Med Officer	FTax Payment	−149 sh	$51.80	−$7,718.2	49,900
2021-09-08	VCYTVERACYTE, INC.S Sale	Chief Scientific & Med Officer	SSale	−926 sh	$50.53	−$46.8K	50,049
2021-09-07	VCYTVERACYTE, INC.M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	+4,406 sh	$5.98	+$26.3K	55,381
2021-09-07	VCYTVERACYTE, INC.M Exercise/Conversion	Chief Scientific & Med Officer	MExercise/Conversion	+3,750 sh	$20.21	+$75.8K	59,131

Recent filings

Accepted (ET)
Dec 84
Kennedy Giulia C0001384101-22-000157
SEC(opens sec.gov)
Dec 64
Kennedy Giulia C0001384101-22-000155
SEC(opens sec.gov)
Nov 154
Kennedy Giulia C0001384101-22-000145
SEC(opens sec.gov)
Nov 84
Kennedy Giulia C0001384101-22-000141
SEC(opens sec.gov)
Sep 74
Kennedy Giulia C0001384101-22-000131
SEC(opens sec.gov)
Aug 94
Kennedy Giulia C0001384101-22-000113
SEC(opens sec.gov)
Jun 64
Kennedy Giulia C0001384101-22-000074
SEC(opens sec.gov)
Mar 94/A
Kennedy Giulia C0001384101-22-000054
SEC(opens sec.gov)

Companies

VERACYTE, INC.Chief Scientific & Med OfficerVCYT

Address

6000 SHORELINE COURT SUITE 300

SOUTH SAN FRANCISCO, CA, 94080